Task: Answer the multiple-choice question.
Question: Which compound exhibits a 12.418% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1nc(SCC#N)c2c(C)c(C)sc2n1
b. O=C1CCCCN1CC(=O)N1CCCC(Nc2ccc(F)cc2)C1
c. CC(Sc1ncn[nH]1)C(=O)c1c(N)n(C)c(=O)n(C)c1=O
Answer: a. Cc1nc(SCC#N)c2c(C)c(C)sc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCC#N)c2c(C)c(C)sc2n1
Cc1nc(SCC#N)c2c(C)c(C)sc2n1
2-(2,5,6-trimethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetonitrile